Enovis sees 11% sales increase in Q2: 7 notes

Claire Wallace -  

Medical technology company Enovis saw an 11 percent increase in net sales during the second quarter of 2022, bringing its total to $395 million, according to the company's financial results released Aug. 4. 

7 things to know about Enovis' second quarter: 

1. Sales growth: On top of an 11 percent revenue increase, Enovis saw a 3 percent increase in organic growth and a 5 percent increase in sales-per-day growth. 

2. Operating income: Enovis' operating income was $6 million. 

3. Earnings per share: Enovis' earnings per share increased to $0.59 from $0.41 in 2021.

4. Earnings before interest, taxes, depreciation and amortization: Enovis experienced an 11% growth in EBITA, reaching $56 million in the second quarter. 

5. Acquisitions: Enovis completed the acquisition of Insight Medical Systems and 360 Med Care in quarter two. 

6. Launches: Enovis launched a new version of its custom recovery boots, ProCare MaxTrax 2.0. 

7. Future growth: Enovis is expecting a 6 to 9 percent growth throughout all of 2022.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

Featured Webinars

Featured Podcast

Featured Whitepapers